Covetrus (CVET) Reports Q1 Loss Per Share of $0.30

Covetrus (NASDAQ: CVET) reported Q1 EPS of ($0.30), may not compare to the analyst estimate of $0.12. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.04 billion.

2020 Financial Guidance

In light of the uncertain product and services demand outlook from our veterinary practice customers caused by COVID-19, Covetrus withdrew its previously issued 2020 financial guidance in a Form 8-K on April 22, 2020. As set forth in the Form 8-K, COVID-19 has and could continue to materially and adversely impact Covetrus' business and results of operations. However, the rapid development and fluidity of this situation precludes any prediction as to the ultimate adverse impact of COVID-19. During the interim period since the filing of the Form 8-K, there has been no material change to the information disclosed therein.

For earnings history and earnings-related data on Covetrus (CVET) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c